|View printer-friendly version|
|January 14, 2005 9:49 a.m.|
|Teva Announces Approval Of Fluconazole Injection|
Jerusalem, Israel, January 14, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval of the Company's ANDA for Fluconazole Injection, 2 mg/mL in 200 mg and 400 mg bags. A launch date has not yet been finalized.